Affiliation:
1. Departments of Anesthesiology and Pain Medicine, Henry Ford Hospital, Detroit, MI.
Abstract
Background: Neuromodulation has been used to treat neuropathic pain. Leads have been
implanted using laminotomy or percutaneous approaches. Laminotomy implantation has been
shown to be superior in terms of lead migration when compared to percutaneous implantation.
Lead migration has been reported as high as 68% with the percutaneous approach. Because of this,
newer anchors have been developed but not tested in vivo.
Objectives: This study tests the hypothesis that newer anchoring systems have improved lead
migration rates for percutaneous leads relative to laminotomy leads to the point of parity. This study
also analyzed if factors such as laterality of symptoms, lead type, level of implant and diagnosis affect
migration rates.
Study Design: Neurostimulators implanted in the thoracolumbar spine at Henry Ford Hospital
between 2006 and 2008 were reviewed for the following: age, sex, diagnosis, lead type, and implant
level. Implants were reviewed for the following: age, sex, diagnosis, lead type, implant level, implant
method, symptom laterality, loss of stimulation, radiographic lead migration, and time to loss. Loss
of capture and lead migration in the laminotomy and percutaneous groups were compared using
Fisher’s exact test. Variables within each group included: lead type, level of implantation, location of
symptoms, and diagnosis. They were compared using Fisher’s exact test. Time to loss of stimulation
was compared using the Wilcoxon 2-sample test.
Setting: Pain Clinic, Henry Ford Hospital, Detroit, MI.
Results: Laminotomies were performed by a single neurosurgeon and percutaneous implants
were performed by a single pain medicine specialist. Percutaneous leads were anchored using Titan
(Medtronic Corporation, Minneapolis, MN) anchors. Loss of capture was 24% laminotomy and 23%
percutaneous with no significant difference between the 2 groups (P = 0.787). Radiographic evidence
of migration was 13.63% percutaneous and 12.67% laminotomy with no significant difference (P
= 0.999). The average days to loss of stimulation for the laminotomy versus percutaneous were as
follows: 124.82 and 323.6 which were not statistically significant. There was no statistical difference
in the days to loss of capture between the groups (P = 0.060). There was no significant difference
between unilateral or bilateral symptoms in loss of capture within either group (P = 0.263, P = 0.326).
There was not enough data to do comparisons by diagnosis. Comparisons of loss of capture based on
electrode type was not significant in either group (P = 0.687, P = 0.371). The effect of the spinal level
on the lack of recapture rates was not able to be calculated due to the number of levels.
Limitations: Retrospective study.
Conclusion: Rates of stimulation loss and radiographic lead migration are similar for both
laminotomy and percutaneous implantation. Time to loss of stimulation was not statistically different
in either group, although there was a trend toward laminotomy leads migrating earlier. Lead type
and laterality of symptoms do not affect lead migration rates. The effect of the level of implant and
diagnosis was indeterminate.
Key words: Neuromodulation, spine, stimulation, complication, migration, pain
Publisher
American Society of Interventional Pain Physicians
Subject
Anesthesiology and Pain Medicine
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献